Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001078
Filing Date
2021-08-09
Accepted
2021-08-09 16:13:40
Documents
74
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q reph-20210630.htm   iXBRL 10-Q 1502520
2 EX-10.1 reph-20210630ex10_1.htm EX-10.1 49339
3 EX-10.2 reph-20210630ex10_2.htm EX-10.2 27784
4 EX-31.1 reph-20210630ex31_1.htm EX-31.1 12500
5 EX-31.2 reph-20210630ex31_2.htm EX-31.2 12478
6 EX-32.1 reph-20210630ex32_1.htm EX-32.1 8364
  Complete submission text file 0000950170-21-001078.txt   7337538

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reph-20210630_lab.xml EX-101.LAB 571487
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT reph-20210630_cal.xml EX-101.CAL 42013
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reph-20210630_pre.xml EX-101.PRE 411078
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reph-20210630.xsd EX-101.SCH 60752
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT reph-20210630_def.xml EX-101.DEF 222354
12 EXTRACTED XBRL INSTANCE DOCUMENT reph-20210630_htm.xml XML 1242993
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

EIN.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 211156642
SIC: 2834 Pharmaceutical Preparations